Pericapsular Nerve Group Block (PENG) for Hip Surgery
Status:
Not yet recruiting
Trial end date:
2023-11-01
Target enrollment:
Participant gender:
Summary
This will be a randomized comparison of pericapsular nerve group (PENG) blocks with
bupivacaine and a placebo control (PENG blocks with normal saline). The overall objective of
the proposed research is to determine the relative risks and benefits of a single-injection
PENG block to provide postoperative analgesia following hip arthroscopy.
Hypothesis 1: Following hip arthroscopy, participants with a PENG block will experience less
pain in the recovery room compared with current standard-of-care as measured with the Numeric
Rating Scale (NRS).
Hypothesis 2: Following hip arthroscopy, participants with a PENG block will consume less
opioid in the operating and recovery rooms compared with current standard-of-care as measured
in oral morphine milligram equivalents.
Primary end point: In order to claim that PENG blocks are superior to placebo overall, at
least one of these two hypotheses must demonstrate PENG superiority while the other cannot
demonstrate inferiority.